No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Abstract Type I interferons act as gatekeepers against viral infection, and autoantibodies that neutralize these signaling molecules have been associated with COVID-19 severity and adverse reactions to the live-attenuated yellow fever vaccine. On this background, we sought to examine whether autoant...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-024-00829-9 |